1 / 11
文档名称:

2015ACP临床实践指南:压疮的治疗.pdf

格式:pdf   大小:412KB   页数:11页
下载后只包含 1 个 PDF 格式的文档,没有任何的图纸或源代码,查看文件列表

如果您已付费下载过本站文档,您可以点这里二次下载

2015ACP临床实践指南:压疮的治疗.pdf

上传人:Q+1243595614 2017/11/9 文件大小:412 KB

下载得到文件列表

2015ACP临床实践指南:压疮的治疗.pdf

文档介绍

文档介绍:CLINICAL GUIDELINE
Treatment of Pressure Ulcers: A Clinical Practice Guideline From the
American College of Physicians
Amir Qaseem, MD, PhD, MHA; Linda L. Humphrey, MD, MPH; Mary Ann Forciea, MD; Melissa Starkey, PhD; and
Thomas D. Denberg, MD, PhD, for the Clinical mittee of the American College of Physicians*
Description: The American College of Physicians (ACP) devel- audience for this guideline includes all clinicians, and the target
oped this guideline to present the evidence and provide clinical patient population is patients with pressure ulcers.
mendations based on parative effectiveness of
mendation 1: ACP mends that clinicians use pro-
treatments of pressure ulcers.
tein or amino acid supplementation in patients with pressure ul-
Methods: This guideline is based on published literature on this cers to reduce wound size. (Grade: weak mendation, low-
topic that was identified by using MEDLINE, EMBASE, CINAHL, quality evidence)
EBM Reviews, the Cochrane Central Register of Controlled Trials,
the Cochrane Database of Systematic Reviews, the Database of mendation 2: ACP mends that clinicians use hy-
Abstracts of Reviews of Effects, and the Health Technology As- drocolloid or foam dressings in patients with pressure ulcers to
sessment database through February 2014. Searches were lim- reduce wound size. (Grade: weak mendation, low-quality
ited to English-language publications. The es evaluated evidence)
for this guideline plete wound healing, wound size mendation 3: ACP mends that clinicians use elec-
(surface area, volume, and depth) reduction, pain, prevention of trical stimulation as adjunctive therapy in patients with pressure
sepsis, prevention of osteomyelitis, recurrence rate, and harms ulcers to accelerate wound healing. (Grade: weak menda-
of treatment (including but not limited to pain, dermatologic tion, moderate-quality evidence)
complications, bleeding, and infection). This guideline grades
the quality of